Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 207, Issue 12, Pages 1888-1897
Publisher
Oxford University Press (OUP)
Online
2013-03-13
DOI
10.1093/infdis/jit105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects
- (2012) R. N. Greenberg et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses
- (2012) Stephen R. Walsh et al. VACCINE
- Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors
- (2011) Stephen R Walsh et al. Expert Review of Vaccines
- Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
- (2010) Nicolas C. Issa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration
- (2010) Marissa B. Wilck et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccination after stem cell transplant: a review of recent developments and implications for current practice
- (2009) Marissa B Wilck et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques
- (2009) Stephen R. Walsh et al. VACCINE
- Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys
- (2009) Lauren E. Grandpre et al. VACCINE
- A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
- (2009) Alfred von Krempelhuber et al. VACCINE
- Myocarditis, Pericarditis, and Dilated Cardiomyopathy after Smallpox Vaccination among Civilians in the United States, January–October 2003
- (2008) Juliette Morgan et al. CLINICAL INFECTIOUS DISEASES
- Ischemic Cardiac Events during the Department of Health and Human Services Smallpox Vaccination Program, 2003
- (2008) David L. Swerdlow et al. CLINICAL INFECTIOUS DISEASES
- Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer
- (2008) Scott S Tykodi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical development of MVA-based therapeutic cancer vaccines
- (2008) Bruce Acres et al. Expert Review of Vaccines
- Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy
- (2008) Thomas C. Greenough et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More